Miret Surgical announces 510k clearance for its percutaneous surgical system. The device allows surgeons to use a 2.4mm percutaneous shaft and interchange standard surgical tools inside or outside the body. CEO Avi Roop commented that “FDA clearance positions Miret Surgical address the general surgery market as well as opportunities in thoracic and orthopedic surgery”. On the recent launch of the Percuvance system he states that “we are excited to enter this market alongside Teleflex medical and work to reduce the invasiveness of surgery”.

Miret Surgical, based in Illinois, was spun out of the Stanford Biodesign Program. The firm’s products in development aim to impact the invasiveness of standard surgical procedures while working to maintain economic and procedural parity with the current standard of care.

Avi Roop
Author: Avi Roop
Avi Roop is Co-founder & CEO of Miret Surgical